Key result
High-voltage QRS complexes lack specificity for LVH, appearing in ~39% of patients without cardiac disease.
Why the study?
The lack of specificity of voltage changes in the Sokolow and Lyon criteria limits their clinical application for diagnosing left ventricular hypertrophy.
Do Sokolow-Lyon voltage criteria for left ventricular hypertrophy accurately predict clinical cardiac disease in patients with otherwise normal electrocardiograms?
Observational
Do Sokolow-Lyon voltage criteria for left ventricular hypertrophy accurately predict clinical cardiac disease in patients with otherwise normal electrocardiograms?
Answers are grounded in this paper and cite their sources.
High-voltage QRS complexes alone lack specificity for clinical cardiac disease, limiting the clinical application of Sokolow-Lyon voltage criteria for left ventricular hypertrophy.
Of an unselected group of otherwise normal electrocardiograms in which the sum of S in V 1 and R in V 5 exceeded 35 mm., 39 per cent came from patients with no clinical evidence of cardiac disease. Of electrocardiograms in which R in AV L exceeded 11 mm., 29 per cent were from patients without cardiac disease. All of the cases in which the voltage was abnormal in both lead aV L and the precordial leads had evident or possible heart disease. Thus, while the voltage indexes for left ventricular hypertrophy of Sokolow and Lyon are useful and easy to apply, the lack of specificity of voltage changes limits clinical application.
No takes yet. Share an insight, caveat, or question.
Cumming et al. (1959) conducted an observational in Left Ventricular Hypertrophy. High-voltage QRS complexes was evaluated on Absence of clinical evidence of cardiac disease. High-voltage QRS complexes lacked specificity for left ventricular hypertrophy, as 39% of ECGs meeting precordial criteria and 29% meeting aVL criteria occurred in patients without cardiac disease.
Synapse has enriched 10 related papers. Consider them for comparative context: